Happening now at #AACR26: Martin Pomper, MD, PhD (@radnucmp @UTSW_Radiology) highlights the renewed momentum in molecular radiotherapeutics and theranostics, exploring how PSMA-targeted strategies could expand radioligand therapy beyond prostate and neuroendocrine cancers. #MoffittAACR26